Table 1.
Age range Years | Non-beriberi compound | Beriberi compound | ||
---|---|---|---|---|
Men | Women | Men | Women | |
<10 | 8 | 11 | 13 | 11 |
10–19 | 5 | 4 | 3 | 5 |
20–29 | 1 | 6 | 7 | 3 |
30–39 | 4 | 3 | 0 | 4 |
40–49 | 2 | 0 | 4 | 1 |
>50 | 0 | 1 | 2 | 2 |
Total | 20 | 1 | 29 | 26 |
15–49 | 10 | 10 | 8 | 9 |
1 Details on the two compounds were obtained in August 1994. They were selected on the basis of containing a high proportion of men in the age range 15–49 years who were the group with greatest vulnerability to beriberi in 1988;
2 The compound names indicate whether symptoms of beriberi occurred (BBC) or did not occur (NBC) in 1988.